1Camm AI, Kirchhof P, Lip G Y, et a1. Guidelines for the manage?ment of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)[J]. Europace, 2010, 12(10): 1360-1420.
2Wann LS, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHAIHRS focused update on the management of patients with atrial fibrilla?tion (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. J Am Coli Cardiol. 2011, 57(11): 1330-1337.
4Flather M, Yusuf S, Kober L, et al. Long-term ACE-inhibitor thera?py in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor Myocardial Infarction Collaborative Group[J]. Lancet, 2000, 355 (9215): 1575-1581.
5Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on mortality and morbidity in patients with severe heart failure. Ran?domized Aldactone Evaluation Study Investigators[J]. N Engl J Med, 1999,341(10): 709-717.
6Carlquist IF, Home BD, Mnhlestein JB, et al. Genotypes of the cyto?chrome P450 isoform, CYP2C9 and the vitamin K epoxide reduc?tase complex subunit I conjointly determine stable dose: a prospec?tive study[J]. JThromb Thrombolysis, 2006, 22(3): 191-197.
2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.
